Wed, Sep 29, 2021
Veeda Clinical Research Limited filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchanges Board of India (SEBI) on Wednesday to raise Rs 831.5 crore through an initial share sale.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.